FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Market Closed - Börse Stuttgart 15:46:10 2024-06-26 EDT | ||
| 14.11 EUR | -2.01% |
|
| Current month | -7.23% | ||
| 1 month | -5.87% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-26 | 14.11 | -2.01% |
| 24-06-25 | 14.4 | +0.49% |
| 24-06-24 | 14.33 | -2.38% |
| 24-06-21 | 14.68 | -3.67% |
| 24-06-20 | 15.24 | +0.40% |
Delayed Quote Börse Stuttgart
Last update June 26, 2024 at 03:46 pm
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | Morgan Stanley |
| WKN | MG0M76 |
| ISIN | DE000MG0M764 |
| Date issued | 2024-03-21 |
| Strike | 63.29 $ |
| Maturity | Unlimited |
| Parity | 1.37 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 15.73 € |
|---|---|
| Lowest since issue | 9.25 € |
| Spread | 0.01 € |
| Spread % | 0.07% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
42.5
USD
Average target price
53.19
USD
Spread / Average Target
+25.16%
- Stock Market
- Certificates
- Certificat
